Wednesday, at the age of 69, Al Biernat died following a seven-month battle with ALS and those who worked closest to him will ...

Pharmaust Limited (AU:NUZ) has released an update. Neurizon Therapeutics Limited has reported promising preclinical results for its lead drug ...

Pharmaust Limited (AU:NUZ) has released an update. Neurizon Therapeutics has announced promising preclinical results for its lead drug ...

A funding boost of more than £78 million will help UCL scientists working to develop a potential treatment for motor neurone disease, for which there is currently no cure and which affects 5,000 ...

While the S&P/ASX 200 Health Care index (ASX:XHJ) was down 1.4% for the past five days, Neuren has soared on positive news.

Zac Brown Band's John Driskell Hopkins is turning his battle with ALS into a mission to help others: "When you're given a ...

Restaurateur Al Biernat passed away on Wednesday, November 13, after being diagnosed with amyotrophic lateral sclerosis, also ...

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

Amyotrophic Lateral Sclerosis Disease Program (PMN267) PMN267 is a humanized IgG1 antibody directed against toxic misfolded TDP-43 as a potential therapeutic target for amyotrophic lateral sclerosis ...

The Oak Ridge Boys are on their “American Made” farewell tour and the group seems sincere about saying goodbye to the ...

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis.

We are particularly interested in studies that integrate engineering breakthroughs with clinical practice to address complex neurological conditions such as: · Alzheimer’s Disease · Amyotrophic ...